- Develop an understanding of the epidemiology, clinical presentation, and diagnostic considerations of COVID-19.
- Evaluate the use of agents with a high level of evidence for the treatment of COVID-19.
- Given an older adult with multiple comorbidities, design an appropriate treatment regimen for COVID-19 according to the guidelines by the National Institutes of Health.
- Compare and contrast the available vaccines for COVID-19.
- Review current COVID-19 vaccine recommendations of the Advisory Committee on Immunization Practices.
TITLE
Winning the Battle Against COVID-19: Seeing the Light at the End of the Tunnel (CPE Only)
DATE
This activity took place on May 04, 2022, at 1pm-2pm EST.Participants who attended the live activity cannot receive credit for this home-study version.
This home study version was released on July 1, 2022. Each user has 365 days of access post-purchase -OR- its expiration date March 1, 2025, whichever occurs first. *This activity is NOT FL Consultant Approved
ACTIVITY FEE
Free for ASCP Members | $15 Non-Members
PRESENTER
Elias Chahine, PharmD, FCCP, FASCP, FFSHP, BCPS, BCIDP
Professor of Pharmacy Practice
Palm Beach Atlantic University Gregory School of Pharmacy
Spencer Durham, PharmD, BCPS, BCIDP
Associate Clinical Professor and Director of Alumni & Professional Affairs
Auburn University Harrison School of Pharmacy
FINANCIAL DISCLOSURE
Spencer Durham: Participated in an advisory board meeting for Theratechnologies in November 2021 for the HIV medication ibalizumab Elias Chahine discloses no relevant financial conflicts of interest with regard to this activity.
ASCP's BCGP webinars are supported in part through a generous grant from the ASCP Foundation
TARGET AUDIENCE
This activity is intended for pharmacists who are interested in: Winning the Battle Against COVID-19: Seeing the Light at the End of the Tunnel
LEARNING OBJECTIVE
At the conclusion of this application-based activity, participants should be able to:
- Develop an understanding of the epidemiology, clinical presentation, and diagnostic considerations of COVID-19.
- Evaluate the use of agents with a high level of evidence for the treatment of COVID-19.
- Given an older adult with multiple comorbidities, design an appropriate treatment regimen for COVID-19 according to the guidelines by the National Institutes of Health.
- Compare and contrast the available vaccines for COVID-19.
- Review current COVID-19 vaccine recommendations of the Advisory Committee on Immunization Practices.
CONTINUING PHARMACY EDUCATION
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
UAN: 0203-0000-22-025-H01-P
Initial Release Date: July 1, 2022
Credits: 1.5 CPE Contact Hours (1 hour of recorded content, 0.5 hours for post-test assessment)
Expiration: April 1, 2025, by 11:59pm ET
HOW TO EARN CREDIT
Post-Test: You will have 3attempts to achieve a 70% or higher on the post-test assessment.
CPE Credit: You must complete the post-test and evaluation within 365 days post purchase or by the expiration date, whichever occurs first to receive credit. ASCP reports CPE attainment to ACPE and NABP via the CPE Monitor system. The course should be posted within 24-48 hours of evaluation completion. It is the responsibility of the participant to provide their correct date of birth (MMDD format) and NABP e-Profile ID on their member or guest profile on the ASCP Website.
PROVIDER CONTACT INFORMATION
For questions about this educational activity, please contact ASCP at: education@ascp.com
Technical Assistance: Help Page